Image via Wikipedia

European Medicines Agency’s Management Board Endorses The Work Programme 2010 And Strengthens The Involvement Of Patients In The Work Of The Agency

The Board endorsed a new strategy to further involve patients and consumers in the work of the Agency. The new strategy makes a number of proposals that considerably widen the scope of patients’ and consumers’ contribution to the Agency. This includes consultation during benefit-risk evaluation of medicines, participation as observers in meetings of the Pharmacovigilance Working Party and contribution to the Agency’s safety communication.

Via MedicalNewsToday

Here is link to document issued by EMEA.